Growing Inclination of Global Cardiac Assist Devices Industry Analysis and Opportunity Assessment 2017-2027
Press Release – 15
Jan 2019
Research
and Development News
--
.
.
Latest
Update
"Cardiac Assist Devices Market: Global Industry Analysis
2012-2016 and Opportunity Assessment 2017-2027"
with Industries Survey | Global Current Growth and Future.
'
'
“Ventricular devices to dominate the
global market with maximum contribution from the left ventricular
assist devices market”
A cardiac assist device supports the heart in case of respiratory failure. Such devices may replace the heart partially or completely. There are different types of cardiac assist devices available in the market such as Ventricular Assist Device and Intra-aortic Balloon Pump. Ventricular assist devices include left ventricular assist devices (LVAD) & right ventricular assist devices (RVAD) used in combination to move blood from the left and right ventricles. External Ventricular Assist Devices are used for temporary support during or after heart surgery. The intra-aortic balloon pump is a polyethylene balloon mounted on a catheter, and is inserted into the aorta through the femoral artery in the leg. The Intra-aortic Balloon Pump assists the heart during both its rest phase and work phase.
A cardiac assist device supports the heart in case of respiratory failure. Such devices may replace the heart partially or completely. There are different types of cardiac assist devices available in the market such as Ventricular Assist Device and Intra-aortic Balloon Pump. Ventricular assist devices include left ventricular assist devices (LVAD) & right ventricular assist devices (RVAD) used in combination to move blood from the left and right ventricles. External Ventricular Assist Devices are used for temporary support during or after heart surgery. The intra-aortic balloon pump is a polyethylene balloon mounted on a catheter, and is inserted into the aorta through the femoral artery in the leg. The Intra-aortic Balloon Pump assists the heart during both its rest phase and work phase.
'
'
The global
market analysis on cardiac assist devices indicates that the market
is expected to be dominated by ventricular assist devices.
Additionally, among the different types of ventricular assist
devices, the left ventricular assist devices segment leads the market
with the highest market size of over US$ 1,400 Mn estimated by the
end of 2027. The overall ventricular assist devices market is
expected to reach a market valuation of over US$ 1,600 Mn by the end
of 2027, growing at a CAGR of 6.1% during the forecast period.
The global market is witnessing an increase in the demand for advanced equipment in the health care industry. This demand is increasing the focus of developed countries towards advanced medical equipment. The demand for new cardiac assist devices has increased in the last few years as such devices enable continuous flow of blood to the heart, require no mechanical bearings, facilitate approval for bridge to transplant, are available in miniature sizes, and are the life-line support for patients seeking to either recover from or wait for a heart transplant. Even the government has increased the funding for research and development initiatives in advanced medical treatment options and target specific drug delivery, placing utmost concern to the safety of patients at all times.
The global market is witnessing an increase in the demand for advanced equipment in the health care industry. This demand is increasing the focus of developed countries towards advanced medical equipment. The demand for new cardiac assist devices has increased in the last few years as such devices enable continuous flow of blood to the heart, require no mechanical bearings, facilitate approval for bridge to transplant, are available in miniature sizes, and are the life-line support for patients seeking to either recover from or wait for a heart transplant. Even the government has increased the funding for research and development initiatives in advanced medical treatment options and target specific drug delivery, placing utmost concern to the safety of patients at all times.
– For
Other Requirement and Enquiry_
https://www.researchmoz.us/enquiry.php?type=E&repid=1834750
'
'
All these
factors are expected to drive the growth of the global cardiac assist
devices market during the period 2017-2027. The markets growth is
also helped by established reimbursements on Medicare in many
regions. Especially in the U.S, Medicare covers reimbursement of
cardiac assist devices procedures when done by a registered hospital
or health care agency. This positive reimbursement scenario
encourages patients to undergo such costly and complicated medical
procedures.
“Growing concerns over the risks related to the use of cardiac assist devices may hinder the growth of the global cardiac assist devices market”
There are certain risks associated with cardiac assist devices. The most common risks include infections, pump thrombus, hemorrhage, arrhythmias, and suction events. Many companies have even incurred losses due to the adverse effects these devices have caused to many patients. Medtronic PLC received warning letters from the FDA due to the clotting related side-effects of their small MVAD device. The Abbott Laboratories product HeartMate II has reported several adverse events in clinical trials such as bleeding, cardiac arrhythmia, localised infection and respiratory failure, which may give a false impression to health care professionals. Such cases have resulted in total product recall, thereby hampering the revenue growth of the global cardiac assist devices market.
“Growing concerns over the risks related to the use of cardiac assist devices may hinder the growth of the global cardiac assist devices market”
There are certain risks associated with cardiac assist devices. The most common risks include infections, pump thrombus, hemorrhage, arrhythmias, and suction events. Many companies have even incurred losses due to the adverse effects these devices have caused to many patients. Medtronic PLC received warning letters from the FDA due to the clotting related side-effects of their small MVAD device. The Abbott Laboratories product HeartMate II has reported several adverse events in clinical trials such as bleeding, cardiac arrhythmia, localised infection and respiratory failure, which may give a false impression to health care professionals. Such cases have resulted in total product recall, thereby hampering the revenue growth of the global cardiac assist devices market.
Continue.....
– More
Clear Details get Full Table of Contents_
https://www.researchmoz.us/cardiac-assist-devices-market-global-industry-analysis-2012-2016-and-opportunity-assessment-2017-2027-report.html/toc
About
Researchmoz,
ResearchMoz
is the world’s fastest growing collection of market research
reports worldwide. Our database is composed of current market studies
from over 100 featured publishers worldwide. Our market research
databases integrate statistics with analysis from global, regional,
country and company perspectives. ResearchMoz’s service portfolio
also includes value-added services such as market research
customization, competitive landscaping, and in-depth surveys,
delivered by a team of experienced Research Coordinators.
-- Researchmoz Global Pvt. Ltd.--
-- Researchmoz Global Pvt. Ltd.--
Mr.
Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
Comments
Post a Comment